Dose-finding trial of tolvaptan in liver cirrhosis patients with hepatic edema: A randomized, double-blind, placebo-controlled trial
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dose-finding trial of tolvaptan in liver cirrhosis patients with hepatic edema: A randomized, double-blind, placebo-controlled trial
Authors
Keywords
-
Journal
HEPATOLOGY RESEARCH
Volume 44, Issue 1, Pages 83-91
Publisher
Wiley
Online
2013-03-27
DOI
10.1111/hepr.12099
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetics, Pharmacodynamics and Safety of Tolvaptan, A Novel, Oral, Selective Nonpeptide AVP V2-receptor Antagonist: Results of Single- and Multiple-Dose Studies in Healthy Japanese Male Volunteers
- (2011) Seong Ryul Kim et al. CARDIOVASCULAR DRUGS AND THERAPY
- Phase III Clinical Pharmacology Study of Tolvaptan
- (2011) Takayuki Inomata et al. CARDIOVASCULAR DRUGS AND THERAPY
- Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH)
- (2011) Natig Gassanov et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Diagnostic criteria of acute liver failure: A report by the Intractable Hepato-Biliary Diseases Study Group of Japan
- (2011) Satoshi Mochida et al. HEPATOLOGY RESEARCH
- Management of ascites in cirrhosis
- (2011) Florence Wong JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Diuretic Strategies in Patients with Acute Decompensated Heart Failure
- (2011) G. Michael Felker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of the G-protein and 2-adrenergic receptor gene and plasma norepinephrine level with clonidine improvement of the effects of diuretics in patients with cirrhosis with refractory ascites: a randomised clinical trial
- (2010) Y. Y. Yang et al. GUT
- A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis
- (2010) Kiwamu Okita et al. JOURNAL OF GASTROENTEROLOGY
- EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis
- (2010) JOURNAL OF HEPATOLOGY
- The 2008 Declaration of Helsinki: some reflections
- (2010) S. Giordano JOURNAL OF MEDICAL ETHICS
- Prolonged use of the vasopressin antagonist tolvaptan is a safe and effective treatment for hyponatremia
- (2010) Rebecca Ireland Nature Reviews Nephrology
- Treatment of Hyponatremia
- (2008) Peter Gross INTERNAL MEDICINE
- Liver cirrhosis
- (2008) Detlef Schuppan et al. LANCET
- Non-peptide arginine-vasopressin antagonists: the vaptans
- (2008) Guy Decaux et al. LANCET
- Evaluation and management of patients with refractory ascites
- (2008) Bahaa Eldeen Senousy et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search